Lv1
68 积分 2025-07-21 加入
The dual SYK/JAK inhibitor cerdulatinib demonstrates rapid tumor responses in a phase 2 study in patients with relapsed/refractory B- and T-cell non-Hodgkin lymphoma (NHL)
5天前
已关闭
Discovery of Selective Irreversible Inhibitors for Bruton’s Tyrosine Kinase
12天前
已完结
A thermogalvanic cell dressing for smart wound monitoring and accelerated healing
3个月前
已完结
Serotype distribution of invasive pneumococcal disease from countries of the WHO Africa, Americas, Eastern Mediterranean, South-East Asia, and Western Pacific regions: a systematic literature review from 2010 to 2021
皖公网安备34019202002308
